Jakafi 10 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FUJRV
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,231
Award facts
- Contract value 100% obligated
- $24,231.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on September 3, 2025, with a ceiling value of $24,231.30. The contract calls for the delivery of Jakafi 10 mg tablets (60-count units), a prescription medication used primarily for myelofibrosis and polycythemia vera treatment. The award carries an ultimate completion date of September 4, 2025, and was issued without a set-aside designation. The place of performance is Park Ridge, Illinois, where DMS Pharmaceutical Group maintains its headquarters and distribution operations.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This overarching IDC framework enables the Defense Logistics Agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, with a consistent portfolio of contract awards demonstrating its capacity to distribute branded and generic prescription drugs, biologics, and medical consumables directly to Department of Defense healthcare sites.
Quick answers
Who was awarded contract SPE2DB25FUJRV?
SPE2DB25FUJRV was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 3, 2025.
How much is contract SPE2DB25FUJRV worth?
The government has obligated $24,231 on SPE2DB25FUJRV.
Is contract SPE2DB25FUJRV an order under another contract?
Yes. SPE2DB25FUJRV is a delivery order under SPE2DB25D9365, an indefinite delivery contract.
Was contract SPE2DB25FUJRV competed?
The extent of competition for SPE2DB25FUJRV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award